January 4th, 2022 Targeting survivin as a potential new treatment for chondrosarcoma of bone Y de Jong, J G van Oosterwijk, A B Kruisselbrink, I H Briaire-de Bruijn, G Agrogiannis, Z Baranski, A H G Cleven, A-M Cleton-Jansen, B van de Water, E H J Danen & J V...
Read ArticleJanuary 4th, 2022 Happy New Year! Another new set of 8 teaching cases has been uploaded to the Johns Hopkins Bone and Soft Tissue Pathology Teaching Website (https://apps.pathology.jhu.edu/bone/). Please note that previous difficulties accessing...
Read ArticleJanuary 3rd, 2022[gallery]
Read ArticleJanuary 1st, 2022Chordoma and Chondrosarcoma of the Skull Base.pdf
Read ArticleDecember 31st, 2021Our GoFundMe is still live! The CS Foundation is committed to improving the treatment of patients living with this rare bone & soft tissue cancer. We are currently raising money for the development of a Patient Registry & Natural History...
Read ArticleDecember 22nd, 2021This is a website we have created geared for educational purposes in bone and soft tissue pathology. A new series of videos that have been uploaded to the site. Will be making multiple videos covering everything you could ever want to know about...
Read ArticleDecember 5th, 2021- Orphan-drug designation follows fast track designation granted to INBRX-109 in conventional chondrosarcoma - Preliminary median progression-free survival (PFS) of 7.4 months and disease control rate of 89% observed in conventional chondrosarcoma...
Read ArticleNovember 23rd, 2021View ORCID ProfileWilliam Cross, Iben Lyskjær, Tom Lesluyes, Steven Hargreaves, Anna-Christina Strobl, Christopher Davies, Sara Waise, Shadi Hames, Dahmane Oukrif, Hongtao Ye, Fernanda Amary, Roberto Tirabosco, Toby Baker, David Barnes,...
Read Article